John Giacona, PhD, PA-C
@giaconajohn.bsky.social
Assistant Professor | Hypertension Specialist
UT Southwestern Medical Center
UT Southwestern Medical Center
Reposted by John Giacona, PhD, PA-C
great HTN JC discussion today on BAXHTN study by Dr. Shawna Nesbitt joined by @dramitkhera.bsky.social @giaconajohn.bsky.social @utswim.bsky.social Interesting that baseline aldosterone in the trial was around 7.5 ng/dL by LCMS with baseline PRA is 1 ng/mlhr. This means that majority of pts have PA
October 3, 2025 at 6:16 PM
great HTN JC discussion today on BAXHTN study by Dr. Shawna Nesbitt joined by @dramitkhera.bsky.social @giaconajohn.bsky.social @utswim.bsky.social Interesting that baseline aldosterone in the trial was around 7.5 ng/dL by LCMS with baseline PRA is 1 ng/mlhr. This means that majority of pts have PA
🏆 First time at Epic Cosmos Datathon—our team took 1st place! Grateful for the collaboration and hands on experience ! @drwanpen.bsky.social Excited to present tomorrow (Oct 3) at Pegasus Park Symposium on “Missed Opportunities: Screening for Primary Aldosteronism” #EpicCosmos #HTN
October 3, 2025 at 12:58 AM
🏆 First time at Epic Cosmos Datathon—our team took 1st place! Grateful for the collaboration and hands on experience ! @drwanpen.bsky.social Excited to present tomorrow (Oct 3) at Pegasus Park Symposium on “Missed Opportunities: Screening for Primary Aldosteronism” #EpicCosmos #HTN
Reposted by John Giacona, PhD, PA-C
Excellent commmentary from @giaconajohn.bsky.social and @drwanpen.bsky.social
October 2, 2025 at 10:16 AM
Excellent commmentary from @giaconajohn.bsky.social and @drwanpen.bsky.social
Reposted by John Giacona, PhD, PA-C
Comparing Management strategies for Primary Aldosteronism: Is it 🍎 versus 🍊 ?
Commentary academic.oup.com/ajh/article-...
based on
academic.oup.com/ajh/article-...
#Hypertension #Aldosteronism
Commentary academic.oup.com/ajh/article-...
based on
academic.oup.com/ajh/article-...
#Hypertension #Aldosteronism
Optimal Treatment of Primary Aldosteronism: Can We Compare Apples to Oranges?
Primary aldosteronism (PA) is an endocrine disorder characterized by inappropriate and excessive aldosterone production.1 PA is a prevalent cause of elevat
academic.oup.com
October 2, 2025 at 10:15 AM
Comparing Management strategies for Primary Aldosteronism: Is it 🍎 versus 🍊 ?
Commentary academic.oup.com/ajh/article-...
based on
academic.oup.com/ajh/article-...
#Hypertension #Aldosteronism
Commentary academic.oup.com/ajh/article-...
based on
academic.oup.com/ajh/article-...
#Hypertension #Aldosteronism
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
September 29, 2025 at 7:03 PM
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
Reposted by John Giacona, PhD, PA-C
Our new study that links high Phosphate diet found in processed food and anxiety behavior and alternation of genes involved in mood regulation in mice. That may explain why we don't feel good after a whopper or a big Mac @hkkimphd.bsky.social @utswim.bsky.social sciencedirect.com/science/arti...
September 23, 2025 at 12:34 AM
Our new study that links high Phosphate diet found in processed food and anxiety behavior and alternation of genes involved in mood regulation in mice. That may explain why we don't feel good after a whopper or a big Mac @hkkimphd.bsky.social @utswim.bsky.social sciencedirect.com/science/arti...
Reposted by John Giacona, PhD, PA-C
great HTN journal club discussing GWAS in primary aldosteronism by @jdmosley-moses.bsky.social @giaconajohn.bsky.social www.ahajournals.org/doi/10.1161/...
September 12, 2025 at 6:04 PM
great HTN journal club discussing GWAS in primary aldosteronism by @jdmosley-moses.bsky.social @giaconajohn.bsky.social www.ahajournals.org/doi/10.1161/...
Reposted by John Giacona, PhD, PA-C
So much fun AHA #Hypertension25 gala dinner learning history of HTN from Bill Cushman and visiting with friends @anastasiasmihaili.bsky.social @giaconajohn.bsky.social @spjuraschek.bsky.social
September 7, 2025 at 1:44 AM
So much fun AHA #Hypertension25 gala dinner learning history of HTN from Bill Cushman and visiting with friends @anastasiasmihaili.bsky.social @giaconajohn.bsky.social @spjuraschek.bsky.social
Reposted by John Giacona, PhD, PA-C
@giaconajohn.bsky.social excellent talk highlights that intensive lowering of BP leads to lower not higher risk of OH based on metaanalysis of RCT by @spjuraschek.bsky.social #Hypertension25 Rx should be titrated to seated BP in OH as per 2025 high BP guidelines
September 6, 2025 at 7:45 PM
@giaconajohn.bsky.social excellent talk highlights that intensive lowering of BP leads to lower not higher risk of OH based on metaanalysis of RCT by @spjuraschek.bsky.social #Hypertension25 Rx should be titrated to seated BP in OH as per 2025 high BP guidelines
Reposted by John Giacona, PhD, PA-C
Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled #Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial ca. 2025 from @asnpublications.bsky.social @escardio.bsky.social
#Nephpearls #NephSky #ESCCongress
👉 journals.lww.com/jasn/fulltex...
#Nephpearls #NephSky #ESCCongress
👉 journals.lww.com/jasn/fulltex...
September 6, 2025 at 3:13 PM
Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled #Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial ca. 2025 from @asnpublications.bsky.social @escardio.bsky.social
#Nephpearls #NephSky #ESCCongress
👉 journals.lww.com/jasn/fulltex...
#Nephpearls #NephSky #ESCCongress
👉 journals.lww.com/jasn/fulltex...
Reposted by John Giacona, PhD, PA-C
Great dinner celebrating #Hypertension25 together near harbor with UTSW group Angie Price @giaconajohn.bsky.social @robynwei.bsky.social @jesslin23.bsky.social and Mu Huang
September 6, 2025 at 12:43 AM
Great dinner celebrating #Hypertension25 together near harbor with UTSW group Angie Price @giaconajohn.bsky.social @robynwei.bsky.social @jesslin23.bsky.social and Mu Huang
Reposted by John Giacona, PhD, PA-C
Dr Karol Watson starts with impactful message top 10 take away message #Hypertension25 high BP as predictor dementia and treatment reduces cognitive decline or dementia by 15% . Once you hit 120/80 , trajectory to high BP is steep. Don’t sit on high BP! @ahascience.bsky.social
September 5, 2025 at 2:41 PM
Dr Karol Watson starts with impactful message top 10 take away message #Hypertension25 high BP as predictor dementia and treatment reduces cognitive decline or dementia by 15% . Once you hit 120/80 , trajectory to high BP is steep. Don’t sit on high BP! @ahascience.bsky.social
Ideal BP < 120/80 mmHg! #Hypertension25
September 5, 2025 at 2:36 PM
Ideal BP < 120/80 mmHg! #Hypertension25
Reposted by John Giacona, PhD, PA-C
Congratulations @robynwei.bsky.social RD/ PhD candidate for her poster #Hypertension25 highlighting underutilization of salt substitute use in the US @giaconajohn.bsky.social details in AHA News release newsroom.heart.org/news/u-s-sur... @ahascience.bsky.social
September 5, 2025 at 1:05 PM
Congratulations @robynwei.bsky.social RD/ PhD candidate for her poster #Hypertension25 highlighting underutilization of salt substitute use in the US @giaconajohn.bsky.social details in AHA News release newsroom.heart.org/news/u-s-sur... @ahascience.bsky.social
Reposted by John Giacona, PhD, PA-C
Honored to present my abstract poster at the AHA #hypertension25 on the prevalence of salt substitute use. Grateful that our work @drwanpen.bsky.social @giaconajohn.bsky.social
@jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...
@jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...
U.S. survey finds salt substitutes rarely used by people with high blood pressure
Research Highlights: Despite their effectiveness in lowering sodium intake and managing blood pressure, salt substitutes were rarely used by people with high blood pressure, according to a review of a...
newsroom.heart.org
September 5, 2025 at 12:58 PM
Honored to present my abstract poster at the AHA #hypertension25 on the prevalence of salt substitute use. Grateful that our work @drwanpen.bsky.social @giaconajohn.bsky.social
@jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...
@jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...
Kicked off the day with a run around Baltimore Harbor 🌊🏃♂️ at #Hypertension25. A reminder that movement matters — let’s keep championing lifestyle and physical activity as powerful tools to reduce CVD and BP! @ahascience.bsky.social
September 5, 2025 at 11:25 AM
Kicked off the day with a run around Baltimore Harbor 🌊🏃♂️ at #Hypertension25. A reminder that movement matters — let’s keep championing lifestyle and physical activity as powerful tools to reduce CVD and BP! @ahascience.bsky.social
Outstanding review of resistant hypertension at #HTN25 by Drs. @drwanpen.bsky.social , Keith Ferdinand, and Ty Gluckman — from current challenges in care to exciting new agents in the pipeline. Great insights into where the field is heading!
September 5, 2025 at 12:21 AM
Outstanding review of resistant hypertension at #HTN25 by Drs. @drwanpen.bsky.social , Keith Ferdinand, and Ty Gluckman — from current challenges in care to exciting new agents in the pipeline. Great insights into where the field is heading!
Reposted by John Giacona, PhD, PA-C
Thank you to AHA for the opportunity to present at AHA HTN scientific session 25 in Baltimore. Having an amazing time meeting and connecting with experts in the field! @drwanpen.bsky.social @giaconajohn.bsky.social
@robynwei.bsky.social
@robynwei.bsky.social
September 4, 2025 at 6:37 PM
Thank you to AHA for the opportunity to present at AHA HTN scientific session 25 in Baltimore. Having an amazing time meeting and connecting with experts in the field! @drwanpen.bsky.social @giaconajohn.bsky.social
@robynwei.bsky.social
@robynwei.bsky.social
Reposted by John Giacona, PhD, PA-C
Great talk #Hypertension25 by @jesslin23.bsky.social in discussing limitations of visual estimation of home BP in clinical decision in Rx HTN in Eyeball study @robynwei.bsky.social @giaconajohn.bsky.social
September 4, 2025 at 3:59 PM
Great talk #Hypertension25 by @jesslin23.bsky.social in discussing limitations of visual estimation of home BP in clinical decision in Rx HTN in Eyeball study @robynwei.bsky.social @giaconajohn.bsky.social
Fantastic opening session at AHA #HTN25 — great energy, insights, and inspiration already flowing. Excited for the great science and rich discussions ahead! @ahascience.bsky.social @drwanpen.bsky.social
September 4, 2025 at 2:05 PM
Fantastic opening session at AHA #HTN25 — great energy, insights, and inspiration already flowing. Excited for the great science and rich discussions ahead! @ahascience.bsky.social @drwanpen.bsky.social
Reposted by John Giacona, PhD, PA-C
Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social
September 3, 2025 at 9:15 PM
Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social
❓What’s new in BP care?
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
August 28, 2025 at 6:54 PM
❓What’s new in BP care?
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
Reposted by John Giacona, PhD, PA-C
Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart
August 19, 2025 at 11:39 PM
Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart
New 2025 AHA/ACC Hypertension Guidelines are out! You will not want to miss this webinar! Sign up 👇
The 2025 AHA/ACC Hypertension GL is out ! @CircAHA www.ahajournals.org/doi/10.1161/... please join us for the Targetbp Webinar as the first platform to digest the GL by @kcferdmd @jordybc.bsky.social and Dan Jones targetbp.org/events/ on August 28
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of...
AIM: The “2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for
the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults”
retires and replaces the...
www.ahajournals.org
August 14, 2025 at 6:12 PM
New 2025 AHA/ACC Hypertension Guidelines are out! You will not want to miss this webinar! Sign up 👇
Reposted by John Giacona, PhD, PA-C
Another great HTN JC by @giaconajohn.bsky.social on AVIM therapy, which just received BDD status. A niche pacemaker for pt with systolic HTN but concerns remain for reduced cardiac output from AV dyssynchrony+ chronic RV pacing. with this high BP variability, how can oscillometric BP be accurate?
August 4, 2025 at 9:01 PM
Another great HTN JC by @giaconajohn.bsky.social on AVIM therapy, which just received BDD status. A niche pacemaker for pt with systolic HTN but concerns remain for reduced cardiac output from AV dyssynchrony+ chronic RV pacing. with this high BP variability, how can oscillometric BP be accurate?